urapidil has been researched along with Urinary Retention in 2 studies
Urinary Retention: Inability to empty the URINARY BLADDER with voiding (URINATION).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yamanishi, T | 2 |
Yasuda, K | 2 |
Kamai, T | 1 |
Tsujii, T | 1 |
Sakakibara, R | 2 |
Uchiyama, T | 1 |
Yoshida, K | 1 |
Tojo, M | 1 |
Hattori, T | 1 |
Shimazaki, J | 1 |
1 trial available for urapidil and Urinary Retention
Article | Year |
---|---|
Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Aged; Bethanechol; Cholinergic Agents; Do | 2004 |
1 other study available for urapidil and Urinary Retention
Article | Year |
---|---|
Improvement of urethral resistance after the administration of an alpha-adrenoceptor blocking agent, urapidil, for neuropathic voiding dysfunction.
Topics: Adrenergic alpha-Antagonists; Aged; Female; Humans; Male; Middle Aged; Nervous System Diseases; Pipe | 1994 |